UA6-32229-84031
2 vaccinations
2 coded responses
22 check-ins
2 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 782 / TX
- Registered
- 2022-07-01
- Relationship
- Child or adolescent in my care
- Guardian
- KEJ-23076-75508
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-29
Dose 1 — Pfizer-BioNTech
-
2022-07-01
Registered in v-safe
-
2022-07-01
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Sleepiness, Irritability/cryingUnder 3 check-in
- 2022-07-02
- 2022-07-03
- 2022-07-04
- 2022-07-05
- 2022-07-06
- 2022-07-13
-
2022-07-20
Dose 2 — Pfizer-BioNTech
- 2022-07-20
- 2022-07-21
- 2022-07-22
- 2022-07-23
- 2022-07-24
- 2022-07-25
- 2022-07-26
- 2022-07-27
- 2022-08-03
- 2022-08-10
- 2022-08-18
-
2022-08-24
Survey response — day 35, dose 2, under 3MedDRA: Herpangina — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: HerpanginaMedDRA releases: 2024-11 · check-in free text available
-
2022-08-24
Report sent to call center — day 35, dose 2, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-08-25
- 2022-08-31
-
2022-10-19
Survey response — 3 months, dose 2, under 3MedDRA: COVID-19, Hand-foot-and-mouth disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Hand foot mouth and COVID-19MedDRA releases: 2024-11 · check-in free text available
-
2022-10-19
Report sent to call center — 3 months, dose 2, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-20
- 2022-10-20
- 2023-01-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-29 | Pfizer-BioNTech | No |
| 2 | 2022-07-20 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 12 (Under 3) — day 35, dose 2, under 3
Symptoms: Herpangina
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: Hand foot mouth and COVID-19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Hand-foot-and-mouth disease | · | · | ✓ |
| SD | Herpangina | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release